Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(CDP6038----1件: 46
22-CdA1件: Cladribine (Synonym: 2-CdA)1件: D01370 1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 13
32-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
42-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
52-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
62-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
72-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
82-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
92-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
102-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
112-chloro-2'-deoxyadenosine (2-CdA)1件: Cladribine (Synonym: 2-CdA)1件: D01370 1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 13
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
132-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (Synonym: 2-CdA)		2件: D00045 ,
D01370 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
142-chloro-2’-deoxyadenosine (2-CdA)1件: Cladribine (Synonym: 2-CdA)1件: D01370 1件: RRM1 💬5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬1件: 13
15Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
16ALLO-ASC-CD----1件: 96
17Anti CD3 monoclonal antibody----1件: 97
18Anti-CD19-CAR-T cells----1件: 49
19Anti-CD20 B cell depletion with Truxima1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 49
20Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46
21Anti-CD25 Humanized Monoclonal Antibody----1件: 13
22Anti-CD28dAb----3件: 49, 53, 160
23Anti-CD31件: Muromonab (Synonym: Anti-CD3)1件: D05092 (Name: Muromonab-CD3)3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 96, 97
24Anti-CD3 Monoclonal antibody1件: Muromonab (Synonym: Anti-CD3)1件: D05092 (Name: Muromonab-CD3)3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬2件: 96, 97
25Anti-CD40L1件: Toralizumab (Synonym: Anti-CD 154 human-mouse monoclonal antibody)1件: D06193 1件: CD40LG 💬14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬1件: 63
26Anti-CD40LdAb----1件: 63
27Anti-CD45----3件: 60, 65, 285
28Anti-CD52 monoclonal antibody----1件: 13
29AP-CD/LD----1件: 6
30Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53
31Autologous CD34+ cell transduced with G2SCID vector----1件: 65
32AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65
33AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19
34Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19
35AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20
36Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65
37Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65
38Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65
39AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65
40Autologous CD34+HPC transplantation (HSCT)----1件: 49
41Autologous CD34-selected peripheral blood stem cells transplant----1件: 96
42Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13
43Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA----1件: 20
44Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51
45BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester2件: Bardoxolone,
Bardoxolone methyl		2件: D09584 ,
D09585 		--1件: 86
46Biologic: IC14 (monoclonal antibody against human CD14)----1件: 2
47Blinded CDCA 250 mg TID1件: Chenodeoxycholic acid (Synonym: CDCA)1件: D00163 1件: NR1H4 💬1件: Bile secretion 💬1件: 263
48BT061 (CD4 monoclonal antibody)----1件: 46
49CARBIDOPA (CD)1件: Carbidopa1件: D00558 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
50CD----7件: 6, 13, 46, 51, 96, 97, 265
51CD-4 guided therapy interruption----1件: 265
52CD-C-Food----1件: 96
53CD-LD CR----1件: 6
54CD-LD IR----1件: 6
55CD19-directed humanised afucosylated monoclonal antibody----1件: 11
56CD19/BCMA CAR T-cells----2件: 16, 61
57CD3-depleted hematopoietic cell transplantation----1件: 60
58CD3/CD19 depleted leukocytes----1件: 284
59CD3/CD19 neg allogeneic BMT----1件: 65
60CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65
61CD3/CD19 negative hematopoietic stem cells----1件: 85
62CD34 selected autologous hematopoietic cells----1件: 51
63CD34 selected haploidentical PBSCT----1件: 285
64CD34 Stem Cell Selection Therapy----3件: 60, 65, 284
65CD34+----1件: 65
66CD34+ bone marrow stem cells intravitreal----1件: 90
67CD34+ CELLS----1件: 285
68CD34+ cells transduced with ADA retrovir----1件: 65
69CD34+ enriched, T Cell Depleted donor stem cell product----1件: 326
70CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65
71CD34+ Peripheral Blood Stem Cell Reinfusion----1件: 49
72CD34+ selected cells----1件: 285
73CD34+CELLS----2件: 65, 285
74CD34+SC----1件: 51
75CD3±CD19 depleted hematopoietic stem cell transplantation----1件: 60
76CD45RA depleted leukocytes----1件: 284
77CD45RA-depleted DLI----1件: 60
78CD62L- Tem----1件: 60
79CD7 CAR T-cells----3件: 50, 96, 97
80CDCA1件: Chenodeoxycholic acid (Synonym: CDCA)1件: D00163 1件: NR1H4 💬1件: Bile secretion 💬1件: 263
81CDCA Weight-Based Dose TID1件: Chenodeoxycholic acid (Synonym: CDCA)1件: D00163 1件: NR1H4 💬1件: Bile secretion 💬1件: 263
82CDMARD----1件: 46
83CDNF----1件: 6
84CDP----1件: 46
85CDP 6038 SC----1件: 46
86CDP3194----1件: 49
87CDP3231件: CDP323---1件: 13
88CDP6038----2件: 46, 96
89CDP7657----1件: 49
90CDP870----3件: 46, 96, 271
91CDP870 100mg----1件: 46
92CDP870 200mg----1件: 46
93CDP870 400mg----1件: 46
94CDP870 Fab'-PEG----1件: 46
95CDX----2件: 222, 240
96CDX 6114----1件: 240
97CDX-1135----1件: 222
98CDZ173----2件: 53, 65
99Cell processing for TCRabeta+/CD19+ depletion----1件: 65
100Cell processing for TCRaß+/CD19+ depletion----1件: 65
101Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi----1件: 19
102Certolizumab pegol (CDP870)1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
103Certolizumab pegol (CDP870, CZP)1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
104Certolizumab pegol (CDP870, tradename Cimzia)1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
105Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
106Chimeric human/mouse anti-CD-20 monoclonal antibody----1件: 46
107CHX A-DTPA anti-CD66 antibody1件: Pentetic acid1件: D05422 --1件: 28
108CHX-A-DTPA-Anti-CD661件: Pentetic acid1件: D05422 --1件: 28
109CliniMACS® CD34 Reagent System cell sorter device----1件: 65
110Combination of a single dose anti-CD20 antibody and bortezomib1件: Bortezomib1件: D03150 1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61
111Companion diagnostic ( CDx)----1件: 51
112Companion diagnostic (CDx)----1件: 96
113Companion Diagnostic (CDx) Testing----1件: 97
114Crohn's disease exclusion diet (CDED)----1件: 96
115CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE----1件: 19
116Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65
117Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65
118Cytolytic CD4+ T cells----1件: 13
119Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant----1件: 62
120D-methylphenidate
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84
121Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: D03639 1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13
122Depletion in CD45RA graft donor----1件: 65
123Depletion of CD3/CD19 in an autologous stem cell transplant----2件: 49, 51
124Diltiazem
(Synonym: Dilt-CD (TN))		1件: Diltiazem (Synonym: Ratio-diltiazem CD)3件: D00616 (Name: Dilt-CD (TN)),
D03830 ,
D07845 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 58, 86
125Diltiazem Gel 2%
(Synonym: Dilt-CD (TN))		1件: Diltiazem (Synonym: Ratio-diltiazem CD)3件: D00616 (Name: Dilt-CD (TN)),
D03830 ,
D07845 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
126Diltiazem Hydrochloride
(Synonym: Dilt-CD (TN))		1件: Diltiazem (Synonym: Ratio-diltiazem CD)3件: D00616 (Name: Dilt-CD (TN)),
D03830 ,
D07845 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
127Duodopa LD/CD 20/5 mg/mL1件: Carbidopa1件: D00558 1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
128EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells----1件: 65
129EF1aS-ADA lentiviral vector transduced patient CD34+ cells----1件: 65
130Engineered humanized monoclonal anti-human CD19 antibody.----1件: 46
131Engineered humanized monoclonal anti-human CD19 antibody. Lot Numbers: 1-FIN-1588 (9.6mg/ml)----1件: 46
132ER CD-LD----1件: 6
133Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector----1件: 65
134Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA.----1件: 36
135Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109
136G1XCGD transduced CD34+ cells----1件: 65
137Gene-Transduced Autologous CD34+ Stem Cells----1件: 65
138Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----1件: 65
139Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101)----1件: 65
140Genetic: Infusion of autologous EFS-ADA LV CD34+ cells----1件: 65
141GSK2018682 CD2 Capsule----1件: 13
142GSK2018682 CD3 micronised Tablet----1件: 13
143GSK2018682 CD3 non-micronised Tablet----1件: 13
144GSK2018682 CD3 non-micronised Tablet in fed state----1件: 13
145Human monoclonal antibody directed against CD20 on B-cells----1件: 46
146Humanised anti-CD 20 antibody----1件: 46
147Humanised anti-CD4 IgG1 monoclonal----1件: 46
148Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97
149HuMax-CD201件: Ofatumumab (Synonym: HuMax-CD20)1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 46
150HUMAX-CD38----2件: 28, 63
151HuMax-CD38, 3003-005----1件: 28
152HuMax-CD4----1件: 46
153Indium 111-radiolabelled anti-CD661件: Indium---1件: 28
154Indium­ 111 ­labelled Anti­-CD661件: Indium---1件: 28
155INEBILIZUMAB
(Synonym: Inebilizumab-cdon)		1件: Inebilizumab (Synonym: inebilizumab-cdon)1件: D11757 (Name: Inebilizumab-cdon)1件: CD19 💬5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬4件: 11, 13, 51, 300
156Intravitreal autologous CD34+ cells----1件: 90
157IPX203 ER CD-LD----1件: 6
158IR CD-LD----1件: 6
159IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
160IR LD / CD----1件: 6
161IR LD/CD----1件: 6
162LD/CD----1件: 6
163Lentiviral vector transduced CD34+ cells----1件: 65
164Levodopa/Carbidopa (LD/CD)2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
165Methylphenidate
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
166Methylphenidate (MPD)
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 6
167Methylphenidate (overencapsulated)
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84
168Methylphenidate 10mg tablets
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84
169METHYLPHENIDATE HYDROCHLORIDE
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13
170Methylphenidate modified release
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
171Methylphenidate modified release 20 mg
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
172Methylphenidate modified release 30 mg
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
173Methylphenidate modified release 40 mg
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		1件: Methylphenidate (Synonym: Metadate CD)2件: D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
174Methylphenidate, fluoxetin, risperidone
(Synonym: METHYLPHENIDATE HYDROCHLORIDE CD)		3件: Fluoxetine,
Methylphenidate (Synonym: Metadate CD),
Risperidone		5件: D00326 ,
D00426 ,
D00823 ,
D01296 (Name: METHYLPHENIDATE HYDROCHLORIDE CD),
D04999 		5件: DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬2件: 179, 206
175Miltenyi CD34 Reagent System----1件: 60
176Muromonab
(Synonym: Muromonab-CD3)		1件: Muromonab (Synonym: Anti-CD3)1件: D05092 (Name: Muromonab-CD3)3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 60
177Muromonab-CD31件: Muromonab (Synonym: Anti-CD3)1件: D05092 (Name: Muromonab-CD3)3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 60
178NI-0401 (anti-CD3 mAB)1件: Muromonab (Synonym: Anti-CD3)1件: D05092 (Name: Muromonab-CD3)3件: CD3D,
CD3E,
CD3G 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 96
179ONO-2160/CD----1件: 6
180Open-Label CDCA 250 mg TID1件: Chenodeoxycholic acid (Synonym: CDCA)1件: D00163 1件: NR1H4 💬1件: Bile secretion 💬1件: 263
181Other: CD LFD----1件: 96
182Other: CD-TREAT diet----1件: 96
183Other: Crohn's disease exclusion diet (CDED)----1件: 96
184Other: Crohn's Disease TReatment-with-EATing diet (CD-TREAT diet)----1件: 96
185Other: Diet-CD----1件: 96
186Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----1件: 65
187Phase1 : CDED/Modulen™IBD® + Maintenance therapy----1件: 96
188Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: D08971 1件: CXCR4 💬12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬1件: 299
189RAG1 LV CD34+ cells----1件: 65
190Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A----1件: 19
191Repair of CDH w/Alloderm----1件: 294
192Repair of CDH w/SIS Gold1件: Gold---1件: 294
193Rescue Medication CDCA 250 mg TID1件: Chenodeoxycholic acid (Synonym: CDCA)1件: D00163 1件: NR1H4 💬1件: Bile secretion 💬1件: 263
194Retroviral SF71-gp91phox transduced CD34+ cells----1件: 65
195Rituximab (anti-CD20)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53
196Routine Treatment of CD----1件: 96
197Semi continuous intra-oral administration of LD/CD----1件: 6
198Standard LD/CD----1件: 6
199Suspension of autologous CD34+cells transduced with the G1XCGD viral vector----1件: 65
200T-Cell Depleted & CD34+Select/w/StemCell Enriched Product----1件: 65
201TL011, anti CD20, for the treatment of rheumatoid arthritis----1件: 46
202Transduced CD34+ Cells----1件: 285
203Transduced patient CD34+ cells----1件: 65
204Yttrium-90 radiolabelled anti-CD66 antibody1件: Yttrium Y-90---1件: 28
205Yttrium­90 radiolabelled anti­CD661件: Yttrium Y-90---1件: 28